Advertisement
Screener

EDESA BIOTECH, INC. (EDSA) Inventory

2.8 / 5 stars · 68/120 Roast Me

EDESA BIOTECH, INC. Inventory

EDESA BIOTECH, INC. (EDSA) had Inventory of $77.91 thousand as of 2019-06-30, per its 10-Q filed 2019-08-14.

Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net

us-gaap:InventoryNet · last filed 2019-08-14

  • 2019-06-30: Inventory, Net $77.91K.
  • 2019-03-31: Inventory, Net $243.97K.
  • 2018-12-31: Inventory, Net $0.00; Inventory, Net as first filed $212.08K.
  • 2018-09-30: Inventory, Net $224.27K.
Period endInventory, NetInventory, Net as first filed
2019-06-30$77.91K
10-Q · filed 2019-08-14
2019-03-31$243.97K
10-Q · filed 2019-05-08
2018-12-31$0.00
10-Q · filed 2019-08-14
$212.08K
10-Q · filed 2019-02-05
2018-09-30$224.27K
10-Q · filed 2019-05-08
2018-06-30$237.49K
10-Q · filed 2018-08-08
2018-03-31$205.36K
10-Q · filed 2018-05-07
2017-12-31$118.54K
10-Q · filed 2018-02-07
2017-09-30$68.11K
10-K · filed 2018-11-30
2017-06-30$140.95K
10-Q · filed 2017-08-09
2017-03-31$310.57K
10-Q · filed 2017-05-09
2016-12-31$329.58K
10-Q · filed 2017-02-06
2016-09-30$249.43K
10-K · filed 2017-12-01
2016-06-30$568.70K
10-Q · filed 2016-08-09
2016-03-31$543.46K
10-Q · filed 2016-05-09
2015-12-31$527.96K
10-Q · filed 2016-02-08
2015-09-30$557.28K
10-K · filed 2016-12-14
2015-06-30$194.37K
10-Q · filed 2015-08-10
2015-03-31$135.15K
10-Q · filed 2015-05-11
2014-12-31$134.31K
10-Q · filed 2015-02-09
2014-09-30$34.89K
10-K · filed 2015-12-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Kairos Pharma, LTD. (KAPA)United States$0.041B